Literature DB >> 19844694

Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil.

Yann K Pittet1, Mette M Berger, Thomas-Thi Pluess, Pierre Voirol, Jean-Pierre Revelly, Luc Tappy, René L Chioléro.   

Abstract

OBJECTIVE: To test the dose response effect of infused fish oil (FO) rich in n-3 PUFAs on the inflammatory response to endotoxin (LPS) and on membrane incorporation of fatty acids in healthy subjects.
DESIGN: Prospective, sequential investigation comparing three different FO doses.
SUBJECTS: Three groups of male subjects aged 26.8 +/- 3.2 years (BMI 22.5 +/- 2.1). INTERVENTION: One of three FO doses (Omegaven10%) as a slow infusion before LPS: 0.5 g/kg 1 day before LPS, 0.2 g/kg 1 day before, or 0.2 g/kg 2 h before. MEASUREMENTS AND
RESULTS: Temperature, hemodynamic variables, indirect calorimetry and blood samples (TNF-alpha, stress hormones) were collected. After LPS temperature, ACTH and TNF-alpha concentrations increased in the three groups: the responses were significantly blunted (p < 0.0001) compared with the control group of the Pluess et al. trial. Cortisol was unchanged. Lowest plasma ACTH, TNF-alpha and temperature AUC values were observed after a single 0.2 g/kg dose of FO. EPA incorporation into platelet membranes was dose-dependent.
CONCLUSIONS: Having previously shown that the response to LPS was reproducible, this study shows that three FO doses blunted it to various degrees. The 0.2 g/kg perfusion immediately before LPS was the most efficient in blunting the responses, suggesting LPS capture in addition to the systemic and membrane effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844694     DOI: 10.1007/s00134-009-1689-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model.

Authors:  E Pscheidl; M Schywalsky; K Tschaikowsky; T Böke-Pröls
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

2.  Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers.

Authors:  Burkhard Michaeli; Mette M Berger; Jean-Pierre Revelly; Luc Tappy; René Chioléro
Journal:  Clin Nutr       Date:  2006-10-18       Impact factor: 7.324

3.  Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects.

Authors:  Thomas-Thi Pluess; Daniel Hayoz; Mette M Berger; Luc Tappy; Jean-Pierre Revelly; Burkhard Michaeli; Yvon A Carpentier; René L Chioléro
Journal:  Intensive Care Med       Date:  2007-03-22       Impact factor: 17.440

4.  Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.

Authors:  Yvonne E Finnegan; Anne M Minihane; Elizabeth C Leigh-Firbank; Samantha Kew; Gert W Meijer; Reto Muggli; Philip C Calder; Christine M Williams
Journal:  Am J Clin Nutr       Date:  2003-04       Impact factor: 7.045

5.  Rapid lipid enrichment in omega3 fatty acids: plasma data.

Authors:  Yvon A Carpentier; Sebastien Peltier; Laurence Portois; Abdullah Sener; Willy J Malaisse
Journal:  Int J Mol Med       Date:  2008-03       Impact factor: 4.101

Review 6.  Immune modulation by parenteral lipid emulsions.

Authors:  Geert J A Wanten; Philip C Calder
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

7.  Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids.

Authors:  Christian M Simoens; Richard J Deckelbaum; Jacques J Massaut; Yvon A Carpentier
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

Review 8.  Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels.

Authors:  G Livesey; M Elia
Journal:  Am J Clin Nutr       Date:  1988-04       Impact factor: 7.045

Review 9.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective.

Authors:  Pierre Singer; Haim Shapiro; Miryam Theilla; Ronit Anbar; Joelle Singer; Jonathan Cohen
Journal:  Intensive Care Med       Date:  2008-05-07       Impact factor: 17.440

Review 10.  n-3 fatty acids, inflammation, and immunity--relevance to postsurgical and critically ill patients.

Authors:  Philip C Calder
Journal:  Lipids       Date:  2004-12       Impact factor: 1.880

View more
  12 in total

Review 1.  Inflammation: depression fans the flames and feasts on the heat.

Authors:  Janice K Kiecolt-Glaser; Heather M Derry; Christopher P Fagundes
Journal:  Am J Psychiatry       Date:  2015-09-11       Impact factor: 18.112

Review 2.  The optimal lipid formulation in enteral feeding in critical illness: clinical update and review of the literature.

Authors:  Craig Munroe; David Frantz; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2011-08

3.  Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis.

Authors:  Sylas B Cappi; Danilo T Noritomi; Irineu T Velasco; Rui Curi; Tatiana C A Loureiro; Francisco G Soriano
Journal:  Intensive Care Med       Date:  2012-02-02       Impact factor: 17.440

4.  Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-01-12       Impact factor: 17.440

Review 5.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

6.  Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord.

Authors:  Hylde Zirpoli; Chuchun L Chang; Yvon A Carpentier; Adina T Michael-Titus; Vadim S Ten; Richard J Deckelbaum
Journal:  Annu Rev Nutr       Date:  2020-09-23       Impact factor: 11.848

7.  Fish oil improves hemodynamic stabilization and inflammation after resuscitation in a rat model of hemorrhagic shock.

Authors:  Yang Li; Xinying Wang; Ning Li; Jieshou Li
Journal:  Lipids Health Dis       Date:  2012-01-10       Impact factor: 3.876

Review 8.  Chronic Critical Illness and PICS Nutritional Strategies.

Authors:  Martin D Rosenthal; Erin L Vanzant; Frederick A Moore
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

9.  Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.

Authors:  Omer Al-Taan; James A Stephenson; Laura Spencer; Cristina Pollard; Annette L West; Philip C Calder; Matthew Metcalfe; Ashley R Dennison
Journal:  Lipids Health Dis       Date:  2013-05-07       Impact factor: 3.876

10.  Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers.

Authors:  Jane F Ferguson; Claire K Mulvey; Parth N Patel; Rhia Y Shah; Julia Doveikis; Weiyu Zhang; Jennifer Tabita-Martinez; Karen Terembula; Michael Eiden; Albert Koulman; Julian L Griffin; Nehal N Mehta; Rachana Shah; Kathleen J Propert; Wen-Liang Song; Muredach P Reilly
Journal:  Mol Nutr Food Res       Date:  2013-11-05       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.